“I would say that we are pleased with these data so far, but we have to interpret the data cautiously,” said study co-author Dr. Dan H. Barouch, a principal investigator […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2018/07/baby.jpg173307Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2018-07-09 12:59:412019-12-29 10:18:21Scientists cautiously optimistic about HIV vaccine candidate
But in the latest report presented this month at the Conference on Retroviruses and Opportunistic Infections in Boston, researchers revealed the strongest evidence yet that these latent viruses can be […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2018/03/hiv-aids-cure.jpg800800Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2018-03-12 16:40:372019-12-29 10:24:34There is no cure for HIV—but scientists may be getting closer
“This meeting started in 2015 and has achieved big success with more than 400 attendees including both basic researchers and clinicians specialized in HIV/AIDS. The purpose is to discuss the most relevant publications (basic science, clinical science and epidemiology/ public health) with one of the co-authors of the publications.”
https://cvvr.hms.harvard.edu/wp-content/uploads/2018/02/ElP-1.jpg12511960Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2018-02-14 18:37:382019-12-29 10:21:36Highlights in Basic and Clinical Research in HIV/AIDS
“Barouch told MD Magazine the push for an HIV vaccine has been gaining momentum.
“We developed a consortium to advance this vaccine over the past several years,” he said. “We are very pleased that multiple funders, stakeholders, and collaborators have been very enthusiastic to work together to move this vaccine forward.”
https://cvvr.hms.harvard.edu/wp-content/uploads/2017/12/red-virus-image.png328410Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2017-12-15 17:25:172019-12-29 09:51:11Push for an HIV Vaccine Gaining Momentum
At the one-year mark, the DNA vaccine was no longer effective, reports professor of medicine Dan Barouch, director of Harvard Medical School’s Center for Virology and Vaccine Research (CVVR) at […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2017/12/zika_info-1.png324409Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2017-12-14 19:49:252019-12-29 10:28:41Harvard Magazine: Toward a Zika Vaccine
https://cvvr.hms.harvard.edu/wp-content/uploads/2017/12/DSC02462.jpg16612500Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2017-12-05 21:57:032019-12-29 10:29:56Dr. Dan Barouch Receives the 2017 Drexel Prize in Immunology
Healthy adults mounted strong immune responses after receiving an investigational whole inactivated Zika virus vaccine, according to interim analyses of three Phase 1, placebo-controlled, double-blind trials conducted at Beth Israel […]
https://cvvr.hms.harvard.edu/wp-content/uploads/2017/12/ZikaA.jpg116197Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2017-12-05 21:49:482019-12-29 10:32:27Zika Vaccine Induces Robust Immune Responses in Three Phase 1 Trials
https://cvvr.hms.harvard.edu/wp-content/uploads/2017/12/NIH-OSC-TCF-logo.png89108Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2017-12-05 21:47:392019-12-29 10:35:17NIH and Partners Launch HIV Vaccine Efficacy Study
As director of Beth Israel Deaconess’s Center for Virology and Vaccine Research, Barouch is behind a new vaccine that could stop the disease [HIV] in its tracks. [Boston Magazine article]
https://cvvr.hms.harvard.edu/wp-content/uploads/2017/12/Dr-Dan-Barouch-1.jpeg822822Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2017-12-05 21:40:592019-12-29 10:39:59Dr. Dan Barouch featured in Boston Magazine
https://cvvr.hms.harvard.edu/wp-content/uploads/2017/10/honor-2-MG_7243.jpeg16672500Academic Web Pageshttps://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.pngAcademic Web Pages2017-10-27 15:08:002019-12-29 10:48:49Dr. Dan Barouch Honored by the Massachusetts Society for Medical Research as Investigator of the Year
Scientists cautiously optimistic about HIV vaccine candidate
/in News“I would say that we are pleased with these data so far, but we have to interpret the data cautiously,” said study co-author Dr. Dan H. Barouch, a principal investigator […]
There is no cure for HIV—but scientists may be getting closer
/in NewsBut in the latest report presented this month at the Conference on Retroviruses and Opportunistic Infections in Boston, researchers revealed the strongest evidence yet that these latent viruses can be […]
Highlights in Basic and Clinical Research in HIV/AIDS
/in News“This meeting started in 2015 and has achieved big success with more than 400 attendees including both basic researchers and clinicians specialized in HIV/AIDS. The purpose is to discuss the most relevant publications (basic science, clinical science and epidemiology/ public health) with one of the co-authors of the publications.”
Push for an HIV Vaccine Gaining Momentum
/in News“Barouch told MD Magazine the push for an HIV vaccine has been gaining momentum.
“We developed a consortium to advance this vaccine over the past several years,” he said. “We are very pleased that multiple funders, stakeholders, and collaborators have been very enthusiastic to work together to move this vaccine forward.”
Harvard Magazine: Toward a Zika Vaccine
/in NewsAt the one-year mark, the DNA vaccine was no longer effective, reports professor of medicine Dan Barouch, director of Harvard Medical School’s Center for Virology and Vaccine Research (CVVR) at […]
Dr. Dan Barouch Receives the 2017 Drexel Prize in Immunology
/in NewsZika Vaccine Induces Robust Immune Responses in Three Phase 1 Trials
/in NewsHealthy adults mounted strong immune responses after receiving an investigational whole inactivated Zika virus vaccine, according to interim analyses of three Phase 1, placebo-controlled, double-blind trials conducted at Beth Israel […]
NIH and Partners Launch HIV Vaccine Efficacy Study
/in NewsPublic-Private Partnership Begins Clinical Trial in Sub-Saharan Africa.[NIH News]
Dr. Dan Barouch featured in Boston Magazine
/in NewsAs director of Beth Israel Deaconess’s Center for Virology and Vaccine Research, Barouch is behind a new vaccine that could stop the disease [HIV] in its tracks. [Boston Magazine article]
Dr. Dan Barouch Honored by the Massachusetts Society for Medical Research as Investigator of the Year
/in News